Education
About Us
Working with TipRanks
Follow Us
Microbot Medical Inc (MBOT)
NASDAQ:MBOT
Total Valuation
Microbot Medical has a market cap or net worth of $91.67M. The enterprise value is $87.32M.
Market Cap$91.67M
Enterprise Value$87.32M
Share Statistics
Microbot Medical has 36,377,810 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding36,377,810
Owned by Insiders0.38%
Owned by Institutions0.30%
Financial Efficiency
Microbot Medical’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is -319.28%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)-319.28%
Return on Capital Employed (ROCE)-3.26
Revenue Per Employee0.00
Profits Per Employee-572.15K
Employee Count20
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio1.46
Price to Fair Value4.96
Price to FCF-9.72
Price to Operating Cash Flow-4.56
PEG Ratio-0.19
Income Statement
In the last 12 months, Microbot Medical had revenue of 0.00 and earned 182.00K in profits. Earnings per share was 0.01.
Revenue0.00
Gross Profit0.00
Operating Income-11.63M
Pretax Income-11.44M
Net Income182.00K
EBITDA-11.35M
Earnings Per Share (EPS)0.01
Cash Flow
In the last 12 months, operating cash flow was -9.28M and capital expenditures -24.00K, giving a free cash flow of -9.30M billion.
Operating Cash Flow-9.28M
Free Cash Flow-9.30M
Free Cash Flow per Share-0.26
Dividends & Yields
Microbot Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.82
52-Week Price Change136.11%
50-Day Moving Average2.55
200-Day Moving Average1.74
Relative Strength Index (RSI)51.73
Average Volume (3m)1.24M
Important Dates
Microbot Medical upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Microbot Medical as a current ratio of 2.37, with Debt / Equity ratio of 0.48%
Current Ratio2.37
Quick Ratio2.37
Debt to Market Cap0.00
Net Debt to EBITDA0.26
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Microbot Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Microbot Medical EV to EBITDA ratio is -1.28, with an EV/FCF ratio of -1.64.
EV to Sales0.00
EV to EBITDA-1.28
EV to Free Cash Flow-1.64
EV to Operating Cash Flow-1.64
Balance Sheet
Microbot Medical has $30.39M in cash and marketable securities with $138.00K in debt, giving a net cash position of -$30.25M billion.
Cash & Marketable Securities$30.39M
Total Debt$138.00K
Net Cash-$30.25M
Net Cash Per Share-$0.83
Tangible Book Value Per Share$0.23
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Microbot Medical is $9.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$9.00
Price Target Upside252.94% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―